Clinical decision-making as the basis for assessing agreement between measures of the International Normalized Ratio

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 1, 2009, Pages 87-93

  Shermock, Kenneth M ^a   Connor, J T ^b   Lavallee, D C ^c   Streiff, M B ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Berry Consultants   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Clinical decision making; Point of care testing; Statistics; Thrombosis; Vitamin K antagonist; Warfarin

Indexed keywords

VITAMIN K GROUP; WARFARIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLAND ALTMAN METHOD; CLINICAL DECISION MAKING; CONTROLLED STUDY; CORRELATION ANALYSIS; FACTORIAL ANALYSIS; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; STATISTICAL MODEL; VALIDATION STUDY;

DECISION MAKING; HUMANS; INTERNATIONAL NORMALIZED RATIO; OBSERVER VARIATION; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; REFERENCE STANDARDS; REFERENCE VALUES; RISK;

EID: 57749192697     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03225.x     Document Type: Article

References (27)

1. Altman DG, Bland JM. Measurement in medicine: The analysis of method comparison studies. Statistician 1983; 32: 307-17.
2. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
3. Shermock KM, Bragg LJ, Connor JT, Fink J, Mazzoli G, Kottke-Marchant K. Differences in warfarin dosing decisions based on International Normalized Ratio measurement with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy 2002; 22: 1397-404.
4. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441-7.
5. Bussey HI, Chiquette E, Bianco TM, Lowder-Bender K, Kranyak MA, Linn WD, Farnett L, Clark GM. A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy 1997; 17: 861-6.
6. Dewitte K, Fierens C, Stockl D, Thienpont LM. Application of the Bland-Altman plot for interpretation of method-comparison studies: A critical investigation of its practice. Clin Chem 2002; 48: 799-801.
7. Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long-term oral anticoagulation therapy: Compariacon with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-17.
8. Murray ET, Fitzmaurice DA, McCahon D. Point of care testing for INR monitoring: Where are we now? Br J Haematol 2004; 127: 373-8.
9. Murray ET, Greaves M. INRs and point of care testing. BMJ 2003; 327: 5-6.
10. Stockl D, Rodriguez Cabaleiro D, Van Uytfanghe K, Thienpont LM. Interpreting method comparison studies by use of the Bland-Altman plot: reflecting the importance of sample size by incorporating confidence limits and predefined error limits in the graphic. Clin Chem 2004; 50: 2216-18.
11. Westgard JO. Points of care in using statistics in method comparison studies. Clin Chem 1998; 44: 2240-2.
12. Westgard JO, Carey RN, Wold S. Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 1974; 20: 825-33.
13. Hobbs FD, Fitzmaurice DA, Murray ET, Holder R, Rose PE, Roper JL. Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings. J Clin Pathol 1999; 52: 494-7.
14. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 1995; 155: 1861-7.
15. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992; 152: 589-92.
16. Reed C, Rickman H. Accuracy of international normalized ratio determined by portable whole-blood coagulation monitor versus a central laboratory. Am J Health Syst Pharm 1999; 56: 1619-23.
17. Reiss RA, Haas CE, Griffis DL, Porter B, Tara MA. Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies. Pharmacotherapy 2002; 22: 677-85.
18. Touchette DR, Popovic B, Racine E, Andersen JC, Massanari MR, Stevenson JG. Correlation and clinical assessment of a portable PT/INR monitor in a cardiology ambulatory clinic. Pharmacotherapy 2000; 20: 1236.
19. van den Besselaar A. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2002; 12: 35-40.
20. Shermock KM, Connor JT, Smith NT, Fink JM, Bragg L. Validity of criteria used to evaluate fingerstick devices that assess international normalized ratio. Med Decis Making 2006; 26: 239-46.
21. Bland JM, Altman DG. Comparing methods of measurement: Why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-7.
22. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists. Chest 2008; 133: 160S-98S.
23. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 204S-33S.
24. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-17.
25. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897-902.
26. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996; 335: 540-6.
27. Schulman S, Beyth R, Kearon C, Levine M. Hemorrhagic complications of anticoagulant and thrombolytic treatment. Chest 2008; 133: 257S-98S.